 |
市场调查报告书
商品编码
1244373
全球超声凝胶市场——增长、趋势、COVID-19 的影响和预测 (2023-2028)Ultrasound Gel Market - Growth, Trends, and Forecasts (2023 - 2028) |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
在预测期内，全球超声凝胶市场预计将以 3.9% 的复合年增长率增长。
COVID-19 对超声凝胶市场的早期影响是由于取消了包括超声诊断在内的选择性程序而产生的负面影响。 例如，2021 年 4 月发表在 Nature Public Health Emergency Collection 上的一篇论文报告说，COVID-19 期间在放射科进行的急诊超声检查减少了 58%。。 然而，市场是由超声波主要用于监测 COVID-19 患者的呼吸活动所推动的。 例如，在2021年3月发表于NCBI的另一篇论文中，使用肺部超声评估COVID-19患者是一种低成本、无辐射、实用、易于消毒的仪器。据说它受到鼓励 超声也促进了 SARS-CoV-2 肺损伤的结构评估。 由于越来越多的超声手术和超声凝胶的新配方，预计未来几年超声凝胶市场将增长。
此外，越来越多的超声手术、技术进步和超声凝胶製备的进步正在有效地推动所研究市场的增长。 此外，在各种治疗方式中增加超声波的使用也可能促进市场增长。 例如，2022 年 4 月发表在 Journal of Material Chemistry B 上的一篇论文描述了超声响应水凝胶的优势。 超声响应水凝胶已用于超声成像、按需药物输送和形状记忆等应用。 因此，超声凝胶等进步有望增加需求，从而促进市场增长。
经过改进的超声凝胶无味、无色、不含甘油和甲醛。 已经对超声凝胶进行了大量研究，以改进其配方并提高其效率。 例如，2022 年 1 月发表在 MDPI 杂誌上的一篇文章使用芦荟凝胶等高度可生物降解的天然成分製备了一种替代超声凝胶配方。 芦荟凝胶对皮肤有抗炎作用。 芦荟还具有皮肤抗炎特性，使用它的配方具有低过敏性，对皮肤敏感的患者来说是安全的。 因此，超声凝胶製备中的此类改进将增加对产品的需求，从而促进市场增长。
此外，主要市场参与者的技术进步、产品批准、发布和合作伙伴关係预计将推动市场增长。 例如，2021 年 2 月，挪威初创公司 SonoClear AS 的新型声学耦合液“SonoClear”在临床试验中註册，以评估其性能和安全性。 这种耦合液可以模拟自然脑电波。 此类临床试验的开展有望推动对创新超声凝胶的需求并推动市场增长。
因此，由于超声凝胶的进步和产品发布的增加，预计该市场在分析期间将会增长。 然而，使用其他替代产品可能会阻碍市场增长。
超声凝胶市场趋势
无菌超声凝胶部分预计在预测期内增长
灭菌超声凝胶用于体外受精手术和阴道/宫内检查的超声检查和活检采集过程。 在超声检查过程中防止感染和微生物传播的最佳方法之一是使用无菌超声凝胶。
无菌凝胶比其他类型的凝胶占有更大的市场份额。 美国健康与安全管理局已发布 2022 年 5 月指南，以确保仅使用未打开的小袋或标有“无菌”标籤的容器。 预计此类法规的颁布将对该行业在分析期间的增长产生积极影响。 此外，需要超声进行更好诊断的疾病的增加将进一步推动对超声凝胶的需求。 例如，根据美国慢性病专业协会 2022 年慢性病预防评论，近 60% 的成年美国人至少患有一种慢性病。 糖尿病、癌症和心血管疾病等慢性病是美国的主要健康问题。 超声成像主要用于诊断慢性病，预计将在预测期内促进该领域的增长。
此外，预计在预测期内，旨在增加无菌超声凝胶可用性的产品发布、合作和伙伴关係将推动市场增长。 例如，2021年1月，以银纳米技术为动力的保健品医疗品牌Nanocare推出了一款无菌超声凝胶。 这种超声凝胶具有粘性，可以消散和减少激光设备产生的热量。
因此，由于无菌超声凝胶的进步、产品发布的增加以及需要超声的慢性疾病的增加，预计所研究的市场在分析期间会出现增长。
在预测期内，预计北美将主导超声凝胶市场。
预计北美市场的增长将受到多种因素的推动，例如需要超声检查的慢性病患病率上升、超声凝胶技术不断进步，以及行业参与者在该地区的强大影响力。预计。
预计慢性病的高患病率将推动超声凝胶在同一地区的增长。 由于超声对于慢性疾病的诊断是必不可少的，因此预计将促进超声凝胶的使用，使诊断更加顺利。 比如美国的慢性肾病，2021年估计超过七分之一的人，也就是美国15%的成年人，也就是3700万人患有CKD。 肾臟疾病，如慢性肾病和肾癌，可以通过适当的超声检查来诊断，因此需要超声凝胶，这有望促进该研究地区的市场增长。
此外，意识的提高、对各种诊断方法的需求不断增加以及各种医疗机构的批准预计将推动该地区的市场增长。 例如，2021 年 3 月，美国医学超声学会 (AIUM) 重新批准了清洁和准备外部和内部超声探头以及安全处理和使用偶联凝胶的指南。 这种批准有望提高超声凝胶在该地区的实用性。
因此，由于需要超声检查的慢性病增加以及产品发布的增加，预计北美在分析期间的监测市场将出现增长。
超声凝胶行业概况
超声凝胶市场因其性质而分散，许多公司不仅在全球范围内开展业务，而且在区域范围内开展业务。 竞争格局包括对几家具有市场份额的知名国际和本地公司的分析。 主要公司包括 Compass Health Brands、Eco-Med Pharmaceutical Inc.、National Therapy Products Inc.、HR Pharmaceuticals Inc.、OJI Group (TELE-PAPER (M) SDN BHD)、Sonogel Vertriebs GmbH、Parker Laboratories Inc.、Scrip Inc、 Besmed Health Business Corporation、Medline Industries、LP、Ultragel Hungary 2000 Kft。
其他福利：
- Excel 格式的市场预测 (ME) 表
- 3 个月的分析师支持
内容
第一章介绍
- 调查假设和市场定义
- 调查范围
第二章研究方法论
第 3 章执行摘要
第四章市场动态
- 市场概览
- 市场驱动因素
- 超声诊断程序的数量增加
- 超声凝胶配方的进展
- 市场製约因素
- 使用其他替代方案
- 波特五力
- 新进入者的威胁
- 买家/消费者的议价能力
- 供应商的议价能力
- 替代品的威胁
- 竞争对手之间的竞争强度
第 5 章市场细分（金额 - 百万美元）
- 按产品类型
- 非无菌
- 已消毒
- 最终用户
- 医院和诊所
- 诊断中心
- 其他最终用户
- 地区
- 北美
- 美国
- 加拿大
- 墨西哥
- 欧洲
- 德国
- 英国
- 法国
- 意大利
- 西班牙
- 其他欧洲
- 亚太地区
- 中国
- 日本
- 印度
- 澳大利亚
- 韩国
- 其他亚太地区
- 中东和非洲
- 海湾合作委员会
- 南非
- 其他中东和非洲地区
- 南美洲
- 巴西
- 阿根廷
- 其他南美洲
- 北美
第六章竞争格局
- 公司简介
- Compass Health Brands
- National Therapy Products Inc.
- HR Pharmaceiuticals Inc.
- OJI Group（TELE-PAPER（M）SDN BHD）
- Sonogel Vertriebs GmbH
- Parker Laboratories Inc.
- Scrip Inc.
- Besmed Health Business Corp.
- Medline Industries, LP
- Ultragel Hungary 2000 Kft.
第7章 市场机会与今后动向
The ultrasound gel market is projected to register a CAGR of 3.9% during the forecast period.
The impact of COVID-19 in its initial phase in the ultrasound gel market was adverse owing to cancellations of elective procedures, including ultrasound diagnosis. For instance, an article published in Nature Public Health Emergency Collection in April 2021 stated that a 58% decrease in emergency department ultrasounds performed by the radiology department was reported during the COVID-19 period. However, the market gained traction as the ultrasound was majorly used in monitoring respiratory activity in COVID-19 patients. For instance, another article published in the NCBI in March 2021 stated use of lung ultrasound in the evaluation of patients with COVID-19 was encouraged because of its low cost, radiation-free, practical method of use, with easy-to-sanitize equipment. The ultrasound facilitated the structural evaluation of lung damage brought on by SARS-CoV-2. The ultrasound gel market is anticipated to witness growth in the coming years due to the rise in the growing number of ultrasound procedures and ultrasound gels with new formulations.
In addition, the growing number of ultrasound procedures, technological advancements, and advancements in ultrasound gel preparation are effectively driving the growth of the studied market. The increased usage of ultrasound in different therapy also likely to boost the market growth. For instance, an article published in April 2022 in the Journal of Material Chemistry B explained the advantages of ultrasound-responsive hydrogel. The ultrasound-responsive hydrogels are used in the applications of ultrasound imaging, on-demand drug delivery, and shape memory. Thus, advancements like ultrasound gel are anticipated to increase the demand, thereby boosting market growth.
Improvements in ultrasound gels to make them odorless, colorless, glycerin-free, and formaldehyde-free. A lot of studies are carried out in ultrasound gel to improve the formula and increase efficiency. For instance, as per the article published in January 2022 in the MDPI journal, an alternative ultrasound gel formulation was prepared using biodegradable and natural ingredients such as aloe vera gel. Aloe vera gel has an anti-inflammatory effect on the skin. The formulation prepared with it is safe for patients with sensitive skin due to its hypoallergenic characteristics. Hence, such improvements included in the preparation of ultrasound gel increase the demand for the products and thereby boosting the market growth.
Moreover, technological advancements, product approvals, launches, and partnerships by key market players are likely to drive market growth. For instance, in February 2021, a new acoustic coupling fluid, SonoClear, from a Norway-based start-up, SonoClear AS, was registered for clinical trials to assess its performance and safety. This coupling fluid can mimic natural brain waves. Such clinical trial developments are projected to boost the demand for innovative ultrasound gel and propel market growth.
Therefore, owing to the increase in advancements in ultrasound gel and the rise in product launches, the studied market is anticipated to witness growth over the analysis period. However, the use of other alternative products is likely to impede the market's growth.
Ultrasound Gel Market Trends
Sterile Ultrasound Gels Segment is Expected to Witness Growth Over the Forecast Period
Sterile ultrasound gel is used for ultrasonography and biopsy sampling processes in in-vitro fertilization surgeries and vaginal and intrauterine examinations. One of the best ways to prevent infection and the spread of microorganisms during an ultrasound procedure is to use sterile ultrasound gel.
The sterile type of gel occupies a significant share of the market compared to other types of gel. The United Kingdom's Health Security Agency, in its May 2022 guidelines, stated to ensure that only unopened sachets and containers that are labeled as 'sterile' are used. The enactment of such regulations is expected to have a positive impact on the growth of the segment over the analysis period. Moreover, growth in the disease prevalence requiring ultrasound for a better diagnosis is likely to further boost the demand for ultrasound gels. For instance, according to the National Association of Chronic Disease Directors, 'Commentary on Chronic Disease Prevention in 2022', nearly 60% of adult Americans have at least one chronic disease. Chronic conditions like diabetes, cancer, and cardiovascular disease are the major health issues in the United States. The diagnosis of chronic diseases majorly employs ultrasound imaging, which is ultimately projected to boost the segment's growth during the forecast period.
Furthermore, product launches, collaborations, and partnerships to increase the availability of sterile ultrasound gel are expected to drive market growth over the forecast period. For instance, in January 2021, Nanocare, a medical brand with health protection products applying Silver Nanotechnology, launched a sterile ultrasonic gel. This ultrasound gel has viscosity to help disperse and reduce the heat generated by the laser device.
Therefore, owing to the increase in advancements in sterile ultrasound gel, the rise in product launches, and the increase in chronic diseases that require an ultrasound, the studied market is anticipated to witness growth over the analysis period.
North America is Expected to Dominate the Ultrasound Gel Market Over the Forecast Period
North America is expected to witness growth in the market owing to factors such as the rising prevalence of chronic diseases that require an ultrasound, increasing technological advancements in ultrasound gel, and the strong presence of industry players in the region.
The high prevalence of chronic diseases is projected to augment the growth of ultrasound gels in the region as the diagnosis of chronic diseases requires an ultrasound to a large extent, which is ultimately projected to boost the use of ultrasound gels for smoother diagnosis. For instance, according to the Chronic Kidney Disease in the United States, 2021, More than 1 in 7, that is 15% of US adults or 37 million people, were estimated to have CKD. Kidney diseases like chronic kidney disease kidney cancer can be diagnosed by proper ultrasound, and thereby requiring the ultrasound gel, which is anticipated to boost the market growth in the studied region.
Also, rising awareness, growing demand for various diagnostic procedures, and approvals by various healthcare institutions are expected to fuel the market growth in this region. For instance, in March 2021, the American Institute of Ultrasound in Medicine (AIUM) reapproved the guidelines for the cleaning and preparation of external and internal ultrasound probes, along with the safe handling and use of coupling gel. Such approvals are projected to boost the utility of ultrasound gels in the region.
Therefore, owing to the increase in chronic diseases that require an ultrasound, and the rise in product launches, North America is anticipated to witness growth in the studied market over the analysis period.
Ultrasound Gel Industry Overview
The ultrasound gel market is fragmented in nature due to the presence of many companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies that hold the market share and are well known. Some of the major players include Compass Health Brands, Eco-Med Pharmaceutical Inc., National Therapy Products Inc., HR Pharmaceuticals Inc., OJI Group (TELE-PAPER (M) SDN BHD), Sonogel Vertriebs GmbH, Parker Laboratories Inc., Scrip Inc., Besmed Health Business Corporation, Medline Industries, LP, and Ultragel Hungary 2000 Kft.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Growing Number of Ultrasound Procedures
- 4.2.2 Advancements in Ultrasound Gels Preparations
- 4.3 Market Restraints
- 4.3.1 Use of Other Alternative Products
- 4.4 Porter Five Forces
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD million)
- 5.1 By Product Type
- 5.1.1 Non-sterile
- 5.1.2 Sterile
- 5.2 By End User
- 5.2.1 Hospitals/Clinics
- 5.2.2 Diagnostic Centers
- 5.2.3 Other End Users
- 5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
- 5.3.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 Compass Health Brands
- 6.1.2 National Therapy Products Inc.
- 6.1.3 HR Pharmaceiuticals Inc.
- 6.1.4 OJI Group (TELE-PAPER (M) SDN BHD)
- 6.1.5 Sonogel Vertriebs GmbH
- 6.1.6 Parker Laboratories Inc.
- 6.1.7 Scrip Inc.
- 6.1.8 Besmed Health Business Corp.
- 6.1.9 Medline Industries, LP
- 6.1.10 Ultragel Hungary 2000 Kft.
